GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (OTCPK:GLPGF) » Definitions » Pre-Tax Income

Galapagos NV (Galapagos NV) Pre-Tax Income : $4.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Galapagos NV Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Galapagos NV's pretax income for the three months ended in Dec. 2023 was $-67.6 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $4.9 Mil. Galapagos NV's pretax margin was 29.66%.

During the past 13 years, Galapagos NV's highest Pretax Margin was 41.88%. The lowest was -302.38%. And the median was -40.06%.


Galapagos NV Pre-Tax Income Historical Data

The historical data trend for Galapagos NV's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Pre-Tax Income Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 165.03 -376.86 -134.92 -75.05 6.13

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67.05 25.12 20.00 27.46 -67.64

Competitive Comparison of Galapagos NV's Pre-Tax Income

For the Biotechnology subindustry, Galapagos NV's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Pre-Tax Income falls into.



Galapagos NV Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Galapagos NV's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-96.252+17.723+-1.93+86.814+-0.22099999999999
=6.1

Galapagos NV's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-75.581+-21.805+3.268+26.702+-0.221
=-67.6

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV  (OTCPK:GLPGF) Pre-Tax Income Explanation

Galapagos NV's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-67.637/-228.052
=29.66%

During the past 13 years, Galapagos NV's highest Pretax Margin was 41.88%. The lowest was -302.38%. And the median was -40.06%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (Galapagos NV) Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.